EZZ Life Science Updates Director’s Shareholding Interests

EZZ Life Science Holdings Ltd. (AU:EZZ) has released an update.

EZZ Life Science Holdings Limited announces a change in the shareholding interests of its director, Glenn Walter Cross. The director has converted 5,000 performance rights into fully paid ordinary shares, increasing his direct shareholding to 45,000 shares. This move may interest investors tracking changes in executive holdings and the potential impact on the company’s stock performance.

For further insights into AU:EZZ stock, check out TipRanks’ Stock Analysis page.